BRADLEY PHARMACEUTICALS, INC.
CONDENSED CONSOLIDATED
BALANCE SHEET
June 30, 2000
(UNAUDITED)
ASSETS
Current assets
--------------
Cash and cash equivalents $ 208,863
Accounts receivable - net 4,289,466
Finished goods inventory 2,075,185
Prepaid samples and materials 486,194
Prepaid expenses and other 88,030
Refundable income tax 294,824
------------
Total current assets 7,442,562
Property and equipment - net 243,521
Intangibles - net 8,547,382
Other assets 133,570
------------
Total Assets $ 16,367,035
============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
-------------------
Current maturities of long-term debt $ 455,270
Revolving credit line 1,165,185
Accounts payable 2,150,905
Accrued expenses 2,302,667
------------
Total current liabilities 6,074,027
Long-term debt, less current maturities 824,522
Commitments & contingencies
Stockholders' equity
--------------------
Preferred stock, $.01 par value;
authorized, 2,000,000 shares; issued, none -
Common stock, $.01 par value, authorized
26,400,000; issued 8,206,289 shares at
June 30, 2000 14,757,786
Common, Class B, $.01 par value, authorized
900,000 shares, issued and outstanding,
431,552 shares at June 30, 2000 845,448
Treasury stock, at cost (730,872 shares at
June 30, 2000) (1,032,722)
Accumulated deficit (5,102,026)
------------
9,468,486
------------
Total Liabilities & Stockholders' Equity $ 16,367,035
============
3